Literature DB >> 34084738

Photodynamic Therapy as an adjunct in the Treatment of Medication-Related Osteonecrosis of the Jaw: A Case Report.

Marcelo Vieira da Costa Almeida1, Antonio C Moura1, Lúcia Santos1, Luciana Gominho2, Ully Dias Nascimento Távora Cavalcanti1, Kaline Romeiro1.   

Abstract

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) corresponds to an adverse effect of the use of drugs such as bisphosphonates and denosumab. This condition is often associated with pain, infection, purulent secretion, paraesthesia, tooth mobility and halitosis, decreasing the patient's quality of life. The management of MRONJ tends to be conservative, through the guidance of oral hygiene, antibiotic therapy and mouthwashes. However, the use of antimicrobial photodynamic therapy (aPDT) has shown promise in the treatment of these injuries. The purpose of this article is to report a case of MRONJ treatment associated with aPDT. Case Report: A 75-year-old patient, with a history of breast cancer and use of intravenous Zoledronic Acid, presented with bilateral MRONJ lesions in tuberosity on the right and left sides. Treatment was conservatively instituted with the use of aPDT as an adjuvant. After 12 aPDT sessions, complete regression of the lesion was observed. However, after two weeks, the presence of a new lesion was noted, this time in the anterior region of the maxilla. The same protocol previously established was followed and after two aPDT sessions, the patient returned with complete lesion regression.
Conclusion: The use of aPDT may represent an important adjuvant within a set of clinical protocols in the treatment of MRONJ.
Copyright © 2021 J Lasers Med Sci.

Entities:  

Keywords:  Bisphosphonates; Low-level laser therapy; MRONJ; Photobiomodulation; Photodynamic therapy

Year:  2021        PMID: 34084738      PMCID: PMC8164899          DOI: 10.34172/jlms.2021.12

Source DB:  PubMed          Journal:  J Lasers Med Sci        ISSN: 2008-9783


  36 in total

Review 1.  Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.

Authors:  A Khan; A Morrison; A Cheung; W Hashem; J Compston
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

2.  Preventing medication-related osteonecrosis of the jaw.

Authors:  Lara Zebic; Vinod Patel
Journal:  BMJ       Date:  2019-05-08

Review 3.  Drug-induced osteonecrosis of the jaw: the state of the art.

Authors:  A Fassio; F Bertoldo; L Idolazzi; O Viapiana; M Rossini; D Gatti
Journal:  Reumatismo       Date:  2017-05-22

4.  Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

Authors:  Jeanny B Aragon-Ching; Yang-Min Ning; Clara C Chen; Lea Latham; Jean-Pierre Guadagnini; James L Gulley; Philip M Arlen; John J Wright; Howard Parnes; William D Figg; William L Dahut
Journal:  Cancer Invest       Date:  2009-02       Impact factor: 2.176

5.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

Review 6.  New cancer therapies and jaw necrosis.

Authors:  V Patel; M Kelleher; C Sproat; J Kwok; M McGurk
Journal:  Br Dent J       Date:  2015-09-11       Impact factor: 1.626

7.  Effects of ionic strength on the antimicrobial photodynamic efficiency of methylene blue.

Authors:  Silvia Cristina Núñez; Aguinaldo Silva Garcez; Ilka Tiemy Kato; Tania Mateus Yoshimura; Laércio Gomes; Maurício Silva Baptista; Martha Simões Ribeiro
Journal:  Photochem Photobiol Sci       Date:  2014-02-04       Impact factor: 3.982

8.  MRONJ risk of adjuvant bisphosphonates in early stage breast cancer.

Authors:  V Patel; J Mansi; S Ghosh; J Kwok; M Burke; D Reilly; N Nizarali; C Sproat; K Chia
Journal:  Br Dent J       Date:  2017-12-15       Impact factor: 1.626

9.  Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

Authors:  Alison T Stopeck; Karim Fizazi; Jean-Jacques Body; Janet E Brown; Michael Carducci; Ingo Diel; Yasuhiro Fujiwara; Miguel Martín; Alexander Paterson; Katia Tonkin; Neal Shore; Paul Sieber; Frank Kueppers; Lawrence Karsh; Denise Yardley; Huei Wang; Tapan Maniar; Jorge Arellano; Ada Braun
Journal:  Support Care Cancer       Date:  2015-09-03       Impact factor: 3.603

Review 10.  Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.

Authors:  Daniele Rosella; Piero Papi; Rita Giardino; Emauele Cicalini; Luca Piccoli; Giorgio Pompa
Journal:  J Int Soc Prev Community Dent       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.